1. Home
  2. ACNB vs MYGN Comparison

ACNB vs MYGN Comparison

Compare ACNB & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$47.25

Market Cap

492.4M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.28

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
MYGN
Founded
1857
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.4M
481.6M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
ACNB
MYGN
Price
$47.25
$4.28
Analyst Decision
Buy
Buy
Analyst Count
1
8
Target Price
$52.00
$7.64
AVG Volume (30 Days)
42.0K
1.7M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
3.20%
N/A
EPS Growth
N/A
N/A
EPS
3.60
N/A
Revenue
$191,821,000.00
$771,400,000.00
Revenue This Year
$13.18
$6.89
Revenue Next Year
$1.91
$5.35
P/E Ratio
$13.18
N/A
Revenue Growth
45.10
2.33
52 Week Low
$35.70
$3.76
52 Week High
$53.89
$8.63

Technical Indicators

Market Signals
Indicator
ACNB
MYGN
Relative Strength Index (RSI) 44.07 36.52
Support Level $42.84 $4.24
Resistance Level $49.13 $5.69
Average True Range (ATR) 1.23 0.32
MACD 0.15 -0.02
Stochastic Oscillator 67.64 2.96

Price Performance

Historical Comparison
ACNB
MYGN

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: